Seroatlas · Human Serome Atlas

SIL1

Nucleotide exchange factor SIL1

Also known as: BAP, MSS, SIL1_HUMAN, ULG5

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
Q9H173
Gene
SIL1
Ensembl
ENSG00000120725
Chromosome
5
Canonical length
461 aa
Protein class
Disease related genes, Human disease related genes, Predicted intracellular proteins
Secretome location
Intracellular and membrane

OverviewNCBI Gene

This gene encodes a resident endoplasmic reticulum (ER), N-linked glycoprotein with an N-terminal ER targeting sequence, 2 putative N-glycosylation sites, and a C-terminal ER retention signal. This protein functions as a nucleotide exchange factor for another unfolded protein response protein. Mutations in this gene have been associated with Marinesco-Sjogren syndrome. Alternate transcriptional splice variants have been characterized. [provided by RefSeq, Jul 2008]

Canonical amino-acid sequenceUniProt

461 residues, UniProt reviewed canonical sequence.

>Q9H173|SIL1
     1  MAPQSLPSSR MAPLGMLLGL LMAACFTFCL SHQNLKEFAL TNPEKSSTKE TERKETKAEE
    61  ELDAEVLEVF HPTHEWQALQ PGQAVPAGSH VRLNLQTGER EAKLQYEDKF RNNLKGKRLD
   121  INTNTYTSQD LKSALAKFKE GAEMESSKED KARQAEVKRL FRPIEELKKD FDELNVVIET
   181  DMQIMVRLIN KFNSSSSSLE EKIAALFDLE YYVHQMDNAQ DLLSFGGLQV VINGLNSTEP
   241  LVKEYAAFVL GAAFSSNPKV QVEAIEGGAL QKLLVILATE QPLTAKKKVL FALCSLLRHF
   301  PYAQRQFLKL GGLQVLRTLV QEKGTEVLAV RVVTLLYDLV TEKMFAEEEA ELTQEMSPEK
   361  LQQYRQVHLL PGLWEQGWCE ITAHLLALPE HDAREKVLQT LGVLLTTCRD RYRQDPQLGR
   421  TLASLQAEYQ VLASLELQDG EDEGYFQELL GSVNSLLKEL R

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against SIL1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Intracellular
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.38
Highest tissue expression
64 nTPM

Expression across tissuesHPA

Tissue

  • pancreas: 64 nTPM
  • choroid plexus: 53 nTPM
  • liver: 52 nTPM
  • testis: 48 nTPM
  • adrenal gland: 46 nTPM
  • skeletal muscle: 41 nTPM

Single-cell type

  • late spermatids: 346 nCPM
  • plasma cells: 318 nCPM
  • myonuclei: 304 nCPM
  • somatotrophs: 290 nCPM
  • hematopoietic stem cells: 289 nCPM
  • podocytes: 268 nCPM

Immune cell

  • intermediate monocyte: 52 nTPM
  • myeloid DC: 51 nTPM
  • classical monocyte: 48 nTPM
  • non-classical monocyte: 43 nTPM
  • plasmacytoid DC: 37 nTPM
  • total PBMC: 27 nTPM

Brain region

  • choroid plexus: 43 nTPM
  • thalamus: 29 nTPM
  • medulla oblongata: 27 nTPM
  • pons: 27 nTPM
  • basal ganglia: 26 nTPM
  • midbrain: 26 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about SIL1.

Disease | AllUniProt

Conditions SIL1 is implicated in, by any mechanism.

Disease | GeneticClinVar

35 pathogenic / likely-pathogenic of 422 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.64
gnomAD pLI
0.01
gnomAD missense Z
0.47
DepMap mean gene effect
-0.08
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of SIL1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads SIL1 as an antibody target. Whether an autoantibody or antibody against SIL1 could matter depends on whether native SIL1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

SIL1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label SIL1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/SIL1. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...